Advertisement

Pancreas Transplantation

  • Andrea Risaliti
  • Nicola Cautero
  • Fabrizio di Francesco
  • Stefano De Luca
Part of the Updates in Surgery book series (UPDATESSURG)

Abstract

Pancreas transplantation, developed to provide a self-regulated endogenous source of responsive insulin to the usual feedback systems, is the only therapy able to establish euglycemic status and standardization of glycosylated hemoglobin in diabetic patients [1, 2]. Despite exogenous insulin support, metabolic control is usually incomplete in diabetic patients, and in the long run diabetes causes many complications, such as retinopathy, sensitive and motorial neuropathy, vascular disease and, in 20–30% of cases, nephropathy.

Keywords

Mycophenolate Mofetil Live Donor Kidney Transplantation Urologic Complication Mesenteric Root Anastomotic Fistula 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sutherland DE (1989) Coming of age for pancreas transplantation. West J Med 150:314–318PubMedGoogle Scholar
  2. 2.
    Coosemans W, Pirenne J (2003) Pancreatic transplantation. Acta Chir Belg 103:73–80PubMedGoogle Scholar
  3. 2.
    Steinman TI, Becker BN, Frost AE et al (2001) Clinical Practice Committee, American Society of Transplantation. Guidelines for the referral and management of patients eligible for solid organ transplantation. Transplantation 71:1189–1204CrossRefPubMedGoogle Scholar
  4. 4.
    Di Carlo A, Odorico JS, Sollinger HW (2004) Pancreas transplantation: an overview. Transplantation Review 1:54Google Scholar
  5. 5.
    Boggi U, Mosca F (2001) I trapianti di pancreas. ETS edizioni, PisaGoogle Scholar
  6. 6.
    Stuart FP, Abecassis MM, Kaufman DB (2000) Il trapianto d’organo. Excerpta Medica, MilanGoogle Scholar
  7. 7.
    Gruessner AC, Sutherland DE (2005) Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 19:433–455CrossRefPubMedGoogle Scholar
  8. 8.
    Vessal G, Wiland AM, Philosophe B et al (2007) Early steroid withdrawal in solitary pancreas transplantation results in equivalent graft and patient survival compared with maintenance steroid therapy. Clin Transplant 21:491–497CrossRefPubMedGoogle Scholar
  9. 9.
    Lai DT, Chu KM, Thompson JF et al (1996) Islet cell carcinoma treated by induction regional chemotherapy and radical total pancreatectomy with liver revascularisation and small bowel autotransplantation. Surgery 119:112–114CrossRefPubMedGoogle Scholar
  10. 10.
    Tzakis AG, Tryphonopoulos P, De Faria W et al (2003) Partial abdominal evisceration, ex vivo resection, and intestinal autotransplantation for the treatment of pathologic lesions of the root of the mesentery. J Am Coll Surg 197:770–776CrossRefPubMedGoogle Scholar
  11. 11.
    Quintini C, Di Benedetto F, Diago T et al (2007) Intestinal autotransplantation for adenocarcinoma of pancreas involving the mesenteric root. Pancreas 34:266–268CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2009

Authors and Affiliations

  • Andrea Risaliti
    • 1
  • Nicola Cautero
    • 1
  • Fabrizio di Francesco
    • 1
  • Stefano De Luca
    • 1
  1. 1.Hepato-Biliary-Pancreatic and Transplantation Unit, Department of Medical and Surgical SciencesPolytechnic University of MarcheAnconaItaly

Personalised recommendations